4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001415889-24-009394
Director bought 1,881.71 shares at $11.82 ($22,242)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haddadin Yezan Munther Director | 2024-03-28 | Purchase | +1,881.71 | $11.82 | $22,242 | 5,048.71 | D |
| Open-market purchases · 1,881.71 sh · avg $11.82 · $22,242 | |||||||
Loading xslF345X05/form4-03292024_020304.xml…